Vietnam

Eisai Establishes Pharma Sales Subsidiary in Vietnam

Tokyo, September 17, 2020: Eisai Co., Ltd. announced today that it has established a new pharmaceutical sales subsidiary in Ho…

4 years ago

Vietnam Clinical Laboratory Market is Expected to Reach over USD 200 Million by 2022: Ken Research

New Delhi, February 28, 2018: Vietnam Clinical Laboratory Market by Labs (Hospital Labs, Independent Labs and Physician Office Labs) and…

7 years ago

Russian infliximab biosimilar has been proved equivalent to Remicade® in international clinical trials

New Delhi, February 21, 2018: In January 2018, BIOCAD’s infliximab biosimilar was approved in Russia. The approval was based on…

7 years ago